Today is proving to be a rough day for the biotech market. In reality, it’s a tough day for the US market in general. As investors take in the fact that the Federal Reserve is planning to increase its interest rate in December, they are balancing portfolios for less risk. This, mixed with poor earnings, … Read more
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Valeant Pharmaceuticals was once an incredibly strong stock. In fact, just two months ago, the stock was trading at $250 per share. That’s kind of hard to believe when you look at it now. After steep declines, VRX closed the last trading session at just over $118 per share. … Read more
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Valeant Pharmaceuticals has been having a rough time in the market since Thursday of last week as federal investigators made the decision to look into the company. Since then, VRX produced a stronger than expected earnings report, but it wasn’t enough to excite investors. Now, an analyst has made … Read more
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) Valeant Pharmaceuticals has had a rough time in the market over the past few trading sessions, and that hard time is continuing today. Even after producing solid earnings, the company can’t seem to get past the major blow that was dealt last week. Today, we’ll talk about the big … Read more
Valeant Pharmaceuticals (NYSE:VRX) On September 28, 2015 shares of Valeant closed the day down approximately 16% after congressional democrats announced that they would file a subpoena to look into the matter about the company’s high priced drugs. The two democrats that filed for this subpoena are Elijah Cummings and Bernie Sanders. More specifically these Democratic … Read more
The US stock market has taken a beating recently, with biotechs taking the brunt of the punishment after comments made by Hillary Clinton. However, today is a relatively green day across the board, and there are several biotech stocks that are making a comeback. Here are 5 biotechs that are making a comeback that’s well … Read more